Anika Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) BEDFORD, Mass., May 03, 2024 (GLOBE NEWSWIRE) -- (NASDAQ: ANIK), a global joint preservation company in early intervention orthopedics, today announced that on May 1, 2024, Anika granted non-statutory stock options (“Options”) covering an aggregate of 3,800 shares of common stock at a per share exercise price of $26.49, which equaled the closing price of common stock on the Nasdaq Global Select Market (“Closing Price”) on the grant date, to one newly hired non-executive employee. The grant was made pursuant to the Anika...
S Split Corp. Declares Monthly Distribution TORONTO, May 03, 2024 (GLOBE NEWSWIRE) -- (TSX: SBN; SBN.PR.A) S Split Corp. has declared monthly distributions, payable on May 31, 2024 to shareholders of record on May 15, 2024. Due to the decline in the net asset value (“NAV”) per unit below $16.50, the Company has suspended distributions on its Class A Shares in accordance with the Articles of Incorporation. The NAV per Unit on April 30, 2024 was $12.03. Share ClassTicker Amount Per ShareClass A SharesSBN$0.00000Preferred SharesSBN.PR.A$0.04375 To the extent that any portions of the d...
Vor Bio Reports Inducement Grant Under Nasdaq Listing Rule 5635(c)(4) CAMBRIDGE, Mass., May 03, 2024 (GLOBE NEWSWIRE) -- Vor Bio (Nasdaq: VOR), a clinical-stage cell and genome engineering company, today announced that, effective as of May 1, 2024, the Compensation Committee of the Board of Directors granted stock options to purchase an aggregate of 31,750 shares of Vor Bio’s common stock and restricted stock units (“RSUs”) representing the right to receive an aggregate of 47,625 shares of Vor Bio’s common stock to six newly hired employees. The foregoing stock options and RSUs were grant...
NewAmsterdam Pharma Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) NAARDEN, the Netherlands and MIAMI, May 03, 2024 (GLOBE NEWSWIRE) -- NewAmsterdam Pharma Company N.V. (Nasdaq: NAMS or “NewAmsterdam” or the “Company”), a late-stage, clinical biopharmaceutical company developing oral, non-statin medicines for patients at risk of cardiovascular disease (“CVD”) with elevated low-density lipoprotein cholesterol (“LDL-C”), for whom existing therapies are not sufficiently effective or well-tolerated, today announced that the Compensation Committee of NewAmsterdam’s Board of Dir...
Verve Therapeutics Announces Inducement Grants under Nasdaq Listing Rule 5635(c)(4) BOSTON, May 03, 2024 (GLOBE NEWSWIRE) -- , a clinical-stage biotechnology company pioneering a new approach to the care of cardiovascular disease with single-course gene editing medicines, today announced that on April 30, 2024, the company granted equity awards to ten new employees, pursuant to the company’s 2024 Inducement Stock Incentive Plan, as an inducement material to each new employee entering into employment with the company in accordance with Nasdaq Listing Rule 5635(c)(4). The employees rece...
Mural Oncology Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) WALTHAM, Mass and DUBLIN, May 03, 2024 (GLOBE NEWSWIRE) -- Mural Oncology plc (Nasdaq: MURA), a clinical-stage immuno-oncology company leveraging its core competencies in immune cell modulation and protein engineering to develop novel, investigational engineered cytokine therapies designed to address areas of unmet need for patients with a variety of cancers, today announced that on May 1, the Company granted to three newly hired employees (i) non-statutory stock options to purchase an aggregate of 20,150 ordina...
Arcutis Biotherapeutics Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) WESTLAKE VILLAGE, Calif., May 03, 2024 (GLOBE NEWSWIRE) -- (Nasdaq: ARQT), a commercial-stage biopharmaceutical company focused on developing meaningful innovations in immuno-dermatology, today reported the grant of an aggregate of 160,500 restricted stock units of Arcutis’ common stock as well as options to purchase an aggregate of 117,000 shares of Arcutis’ common stock to 13 newly hired employees. These awards were approved by the Compensation Committee of Arcutis’ Board of Directors and granted und...
Moody's Ratings (Moody's) has upgraded the ratings on the following notes issued by OZLM VIII, LTD.: U.S.$29,100,000 Class B-R3 Senior Secured Deferrable Floating Rate Notes due 2029 (the "Class B-R3 Notes"), Upgraded to Aaa (sf); previously on June 9, 2023 Upgraded to Aa1 (sf) U.S.$36,900,000 Class...
ATHM will report 1Q24 results on May 8th before the markets open with an 8 am ET conference call. We are positive about ATHM’s 1Q24 performance. The auto market in China continues to improve driven by EV sales. The market share of EV cars has already reached 31.1% in China. With aggressive competition in the EV area, ATHM has become one of the most wanted platforms for market and customer acquisition. As China is adopting auto trade-in measures, we believe auto sales is likely to go up further t...
BABA will report FY4Q24 results on May 14th before the markets open with a 7:30am ET conference call. We believe BABA’s FY4Q24E performance is likely to be in line, but we are positive about the longer-term outlook. BABA is adopting a new strategy focusing on user acquisitions for each business unit, including e-commerce business, cloud business, cross-border commerce, and local services. The company started to use low prices and subsidies. As such, while we expect BABA’s business to resume grow...
JD will report 1Q24 results on May 16th before the US markets open with an 8am ET conference call. Due to multiple stimulating measures from the government, particularly the relaxation of the limitation for top-tier city housing purchases, we expect China’s economy to resume better growth soon. As such, JD is likely to benefit from that.
CALABASAS, Calif.--(BUSINESS WIRE)-- , a leading commercial real estate brokerage firm specializing in investment sales, financing, research and advisory services, announced today its 2024 Cold Storage Special Report, which highlights the strategic advantages of investing in cold storage properties. “A rapid rise in online grocery sales has spurred demand for temperature-controlled storage facilities,” said Alan L. Pontius, national director of Marcus & Millichap’s Office & Industrial division. “From 2019 to 2023, share of total online grocery store spending grew 470 basis points to an all-t...
New York , May 3, 2024 – Moody's Ratings ("Moody's") has affirmed the Baa2 global scale insurance financial strength (IFS) rating of Compañía Aseguradora de Fianzas S.A. Confianza ("Confianza"). The company's rating outlook remains stable. The affirmation of Confianza's Baa2 rating reflects the comp...
Moody's Ratings (Moody's) has affirmed Waconia Independent School District 110, MN's issuer rating and outstanding general obligation unlimited tax (GOULT) ratings at Baa3 and the district's outstanding certificate of participation (COP) rating at Ba1. As of fiscal 2023 (year-end June 30), the distr...
Nokia Corporation: Repurchase of own shares on 03.05.2024 Nokia CorporationStock Exchange Release03 May 2024 at 22:30 EEST Nokia Corporation: Repurchase of own shares on 03.05.2024 Espoo, Finland – On 03 May 2024 Nokia Corporation (LEI: 549300A0JPRWG1KI7U06) has acquired its own shares (ISIN FI0009000681) as follows: Trading venue (MIC Code)Number of sharesWeighted average price / share, EUR*XHEL379,8083.44CEUX--BATE--AQEU--TQEX--Total379,8083.44 * Rounded to two decimals On 25 January 2024, Nokia announced that its Board of Directors is initiating a share buyback program to return up to...
Nokia Oyj: Omien osakkeiden takaisinosto 03.05.2024 Nokia OyjPörssitiedote03.05.2024 klo 22.30 Nokia Oyj: Omien osakkeiden takaisinosto 03.05.2024 Espoo – Nokia Oyj (LEI: 549300A0JPRWG1KI7U06) on 03.05.2024 hankkinut omia osakkeitaan (ISIN FI0009000681) omistukseensa seuraavasti: Markkinapaikka (MIC Code)Osakkeiden lukumääräPainotettu keskihinta osakkeelta, euroa*XHEL379 8083,44CEUX--BATE--AQEU--TQEX--Yhteensä379 8083,44 * Kahden desimaalin tarkkuuteen pyöristettynä Nokia ilmoitti 25. tammikuuta 2024, että yhtiön hallitus on käynnistämässä osakkeidensa takaisinosto-ohjelman palauttaakse...
Moody's Ratings (Moody's) has affirmed University of Cincinnati's (OH) existing Aa3 issuer rating, Aa3 General Receipts bonds and A1 lease revenue bonds. Concurrently, Moody's has assigned Aa3 ratings to the university's $185 million of General Receipts Bonds, Series 2024A; $50 million of Taxable Ge...
Unfortunately, this report is not available for the investor type or country you selected.
Report is subscription only.
Thank you, your report is ready.
Thank you, your report is ready.